218 related articles for article (PubMed ID: 9173771)
1. [Postmenopausal hormone substitution and its effects on the climacteric syndrome, body weight and blood pressure].
Fritsch H; Fritsch W; Julius U; Rehak E; Wieczorek A; Hanefeld M
Zentralbl Gynakol; 1997; 119(3):128-32. PubMed ID: 9173771
[TBL] [Abstract][Full Text] [Related]
2. [Effect of combined conjugated estrogen-medrogestone replacement therapy on lipid profiles, climacteric symptoms and the endometrium].
Belaisch J; Nappi C; Affinito P; De Gezelle H; Botelho M; Oliveira HM; Martinez-Oliveira J; Gonzaga F
J Gynecol Obstet Biol Reprod (Paris); 2000 Feb; 29(1):29-40. PubMed ID: 10675831
[TBL] [Abstract][Full Text] [Related]
3. Effects of low-dose continuous combined conjugated estrogens and medroxyprogesterone acetate on menopausal symptoms, body weight, bone density, and metabolism in postmenopausal women.
Gambacciani M; Ciaponi M; Cappagli B; Genazzani AR
Am J Obstet Gynecol; 2001 Nov; 185(5):1180-5. PubMed ID: 11717654
[TBL] [Abstract][Full Text] [Related]
4. Effects of conjugated equine oestrogens with and without the addition of cyclical medrogestone on hot flushes, liver function, blood pressure and endocrinological indices.
Sonnendecker EW; Polakow ES
S Afr Med J; 1990 Mar; 77(6):281-5. PubMed ID: 2156343
[TBL] [Abstract][Full Text] [Related]
5. Hormone therapy in women in the menopause transition. Randomised, double-blind, placebo-controlled trial of effects on body weight, blood pressure, lipoprotein levels, antithrombin III activity, and the endometrium.
Khoo SK; Coglan MJ; Wright GR; DeVoss KN; Battistutta D
Med J Aust; 1998 Mar; 168(5):216-20. PubMed ID: 9539899
[TBL] [Abstract][Full Text] [Related]
6. Effects of the combined hormonal replacement drug estradiol valerate/levonorgestrel on climacteric complaints, endometrium and lipid profile of peri- and postmenopausal women.
Georgiev DB; Golbs S; Goudev A
Methods Find Exp Clin Pharmacol; 2001 May; 23(4):197-202. PubMed ID: 11676228
[TBL] [Abstract][Full Text] [Related]
7. [Evaluation of the climacteric symptomatology modifications and clinical-instrumental parameters in women in physiological menopause treated with hormone replacement therapy with nomegestrol acetate and in surgical menopause treated with estrogen replacement therapy. Part I].
Savoca S; D'Agosta S; Lombardo G
Minerva Ginecol; 2007 Jun; 59(3):205-14. PubMed ID: 17576399
[TBL] [Abstract][Full Text] [Related]
8. Randomized clinical trial comparing conjugated equine estrogens and isoflavones in postmenopausal women: a pilot study.
Kaari C; Haidar MA; JĂșnior JM; Nunes MG; Quadros LG; Kemp C; Stavale JN; Baracat EC
Maturitas; 2006 Jan; 53(1):49-58. PubMed ID: 16257151
[TBL] [Abstract][Full Text] [Related]
9. Serum estrogen level after hormone replacement therapy and body mass index in postmenopausal and bilaterally ovariectomized women.
Yasui T; Uemura H; Umino Y; Takikawa M; Saito S; Kuwahara A; Matsuzaki T; Maegawa M; Furumoto H; Miura M; Irahara M
Maturitas; 2005 Jan; 50(1):19-29. PubMed ID: 15590210
[TBL] [Abstract][Full Text] [Related]
10. [Italian multicenter study for the verification of the efficacy and tolerability of short-term substitution hormone therapy using conjugated estrogens and progestagens administered orally in the postmenopausal a period].
De Aloysio D; Mauloni M; Altieri P; Cappi GP; Monterubbianesi M; Bottiglioni F
Minerva Ginecol; 1992 Dec; 44(12):629-39. PubMed ID: 1491771
[TBL] [Abstract][Full Text] [Related]
11. Efficacy comparison of Pueraria mirifica (PM) against conjugated equine estrogen (CEE) with/without medroxyprogesterone acetate (MPA) in the treatment of climacteric symptoms in perimenopausal women: phase III study.
Chandeying V; Sangthawan M
J Med Assoc Thai; 2007 Sep; 90(9):1720-6. PubMed ID: 17957910
[TBL] [Abstract][Full Text] [Related]
12. Effect of climacteric transition and hormone replacement therapy on body weight and body fat distribution.
Genazzani AR; Gambacciani M
Gynecol Endocrinol; 2006 Mar; 22(3):145-50. PubMed ID: 16835076
[TBL] [Abstract][Full Text] [Related]
13. Climacteric symptom control after the addition of low-dose esterified conjugated estrogens to raloxifene standard doses.
Carranza-Lira S; Gooch AL; Saldivar N; Osterwalder MS
Int J Fertil Womens Med; 2007; 52(2-3):93-6. PubMed ID: 18320867
[TBL] [Abstract][Full Text] [Related]
14. Effects of four different regimens of hormone replacement therapy on hemostatic parameters: a prospective randomized study.
Taner MZ; Ozpolat E; Taskiran C; Onan MA; Gursel T; Karabulut E; Gursoy R; Himmetoglu O
Maturitas; 2006 Feb; 53(3):267-73. PubMed ID: 15978753
[TBL] [Abstract][Full Text] [Related]
15. Raloxifene lowers serum lipoprotein(A) in healthy postmenopausal women: a randomized, double-blind, placebo-controlled comparison with conjugated equine estrogens.
Mijatovic V; van der Mooren MJ; Kenemans P; de Valk-de Roo GW; Netelenbos C
Menopause; 1999; 6(2):134-7. PubMed ID: 10374220
[TBL] [Abstract][Full Text] [Related]
16. [Low-dose estrogens in the treatment of the climacteric syndrome].
Kolarov G; Nalbanski B; Kamenov Z; Protich M; Obretsova M; Sirakov M
Akush Ginekol (Sofiia); 1998; 37(4):1-4. PubMed ID: 10360038
[TBL] [Abstract][Full Text] [Related]
17. Gradual discontinuation of hormone therapy does not prevent the reappearance of climacteric symptoms: a randomized prospective study.
Haimov-Kochman R; Barak-Glantz E; Arbel R; Leefsma M; Brzezinski A; Milwidsky A; Hochner-Celnikier D
Menopause; 2006; 13(3):370-6. PubMed ID: 16735933
[TBL] [Abstract][Full Text] [Related]
18. Nondipping status does not attenuate the conjugated estrogen-induced improvement in aortic stiffness in postmenopausal women with untreated hypertension.
Tsioufis C; Tzioumis K; Dimitriadis K; Chatzis D; Skiadas I; Michailidis A; Toutouzas P; Kallikazaros I; Stefanadis C
Am J Hypertens; 2005 May; 18(5 Pt 1):607-11. PubMed ID: 15882542
[TBL] [Abstract][Full Text] [Related]
19. Alleviation of the climacteric symptoms with oral sequential hormone replacement therapy.
Chittacharoen A; Domhardt R; Manonai J; Theppisai U; Golbs S
J Med Assoc Thai; 2004 Jan; 87(1):1-7. PubMed ID: 14971528
[TBL] [Abstract][Full Text] [Related]
20. Flow resistance in carotid and middle cerebral arteries in postmenopausal women: a comparative study of tibolone and continuous combined hormone replacement therapy.
Pan HA; Wang ST; Chen CH; Pai MC; Wu MH; Huang KE
Climacteric; 2002 Sep; 5(3):259-65. PubMed ID: 12419084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]